rs1018806781
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004239.4(TRIP11):c.1547A>G(p.Asp516Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000248 in 1,612,710 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004239.4 missense
Scores
Clinical Significance
Conservation
Publications
- achondrogenesis type IAInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Laboratory for Molecular Medicine
- TRIP11-related skeletal dysplasiaInheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TRIP11 | ENST00000267622.8 | c.1547A>G | p.Asp516Gly | missense_variant | Exon 11 of 21 | 1 | NM_004239.4 | ENSP00000267622.4 | ||
| TRIP11 | ENST00000554357.5 | c.692A>G | p.Asp231Gly | missense_variant | Exon 5 of 15 | 1 | ENSP00000451032.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000401 AC: 1AN: 249582 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460494Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 726608 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74374 show subpopulations
ClinVar
Submissions by phenotype
Achondrogenesis, type IA Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleteroius"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with TRIP11-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces aspartic acid with glycine at codon 516 of the TRIP11 protein (p.Asp516Gly). The aspartiic acid residue is weakly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at